Arancha Cebrián Aranda
5PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 12, 2024
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.Anxo Rio-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista
|Jun 24, 2022
Choline Kinase α Inhibitors MN58b and RSM932A Enhances the Antitumor Response to Cisplatin in Lung Tumor Cells.Juan Carlos Lacal, Rosario Perona, Javier de Castro
|Apr 09, 2021
Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes.Barbara Manzanares-Martin, Arancha Cebrián Aranda, Laura Del Puerto-Nevado
Pageof 1
